7 Min Read
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stocks were set to open higher on Wednesday, a day after notching their steepest fall in three weeks as the dollar enjoyed its biggest rally in two years.
Dow Jones industrial average futures were up 0.11 percent at 18,072, S&P 500 futures were up 0.08 percent at 2,106.75 and Nasdaq 100 futures were up 0.16 percent at 4,487.
** MICHAEL KORS HOLDINGS LTD, Tuesday close $60.59, -17.81 pct premarket
Michael Kors reported its slowest growth in quarterly revenue since it went public in December 2011 as demand for its handbags and accessories weakened in North America.
** TIFFANY & CO, Tuesday close $85.53, +7.74 pct premarket
The luxury jeweler Tiffany reported better-than-expected quarterly profit and sales, helped by strong demand for its Tiffany T line and higher sales in the Americas and Europe.
** GLOBEIMMUNE INC, Tuesday close $8.24, -61.65 pct premarket
The company said its experimental hepatitis B drug failed to meet its main goal in a mid-stage trial.
** CHICO'S FAS, Tuesday close $16.72, -6.10 pct premarket
The women's apparel retailer reported first-quarter sales that missed analysts' average estimate, reflected approximately flat average dollar sale and transaction count.
** EMERALD OIL INC, Tuesday close $5.21, +61.42 pct premarket
The oil producer said it would not proceed with a stock offering, citing the current market environment and the associated dilution to shareholders. As a result, the company said it won't close a previously announced Delaware basin acquisition. Emerald Oil also reiterated its 2015 capex and production forecasts.
** OPEXA THERAPEUTICS INC, Tuesday close $0.3849, +21.72 pct premarket
Maxim started coverage of the stock with a "buy" rating and $5 price target, citing substantial opportunity for Tcelna, being developed to treat a severe form of multiple sclerosis. The only other brokerage covering the stock also rates it "buy".
** NANOSPHERE INC, Tuesday close $3.54, +7.63 pct premarket
SWK Holdings Corp reported 6.4 percent passive stake in the drug developer as of May 14.
** FIVE PRIME THERAPEUTICS INC, Tuesday close $19.67, +15.61 pct premarket
** BLUEBIRD BIO INC, Tuesday close $183.69, +1.26 pct premarket
The two companies signed a licensing deal to develop a cancer cell therapy. Five Prime got $1.5 million upfront payment, while bluebird received exclusive rights to Five Prime's novel human antibodies.
** WORKDAY INC, Tuesday close $92.49, -9.45 pct premarket
The human resource software company forecast current-quarter billings below market expectations and reported a bigger quarterly net loss due to higher spending on marketing and product development.
** OXIGENE INC, Tuesday close $1.38, +10.87 pct premarket
The cancer drug developer received U.S. patent for its cancer drug, OXi4503, to treat myeloid neoplasms, including acute myeloid leukemia (AML).
The drug is being tested in an investigator-sponsored early stage study at the University of Florida in patients with relapsed and refractory AML and myelodysplastic syndrome.
** FRONTIER COMMUNICATIONS CORP, Tuesday close $4.92, +5.08 pct premarket
Morgan Stanley upgraded the U.S. regional telephone operator's stock to "overweight" from "underweight." The stock has taken a hit due to pending financing to buy Verizon's wireline assets, analysts said.
** DSW INC, Tuesday close $34.25, +3.36 pct premarket
The footwear and accessories retailer reported better-than-expected first-quarter revenue and profit. Healthy regular priced sales and lower clearance inventory than last year drove significant improvement in gross profit rate, CEO Mike MacDonald said.
** PLUG POWER INC, Tuesday close $2.58, +4.65 pct premarket
The fuel-cell maker said it would supply its flagship GenKey product to a large footwear maker in North America, which has identified the first three sites and is evaluating adopting the units in 30 sites globally.
** HYDROGENICS CORP, Tuesday close $9.02, +35.14 pct premarket
The Canadian fuel-cell maker signed a 10-year agreement, valued at over $54 million, to supply its hydrogen fuel-cell systems for use in for Alstom's regional commuter trains in Europe.
** RETROPHIN INC, Tuesday close $26.87, +10.72 pct premarket
The drugmaker agreed to sell its rare pediatric disease priority review voucher (pediatric PRV) to French drugmaker Sanofi SA for about $245 million.
** HORMEL FOODS CORP, Tuesday close $56.61, +4.42 pct premarket
Hormel Foods said it would buy natural and organic meat processor Applegate Farms LLC for about $775 million to cater to an increasing demand for food free of antibiotics, hormones and artificial additives.
** XBIOTECH INC, Tuesday close $20.22, +17.61 pct premarket
The drugmaker said it successfully cloned an anti-Ebola product candidate using its antibody platform, which is derived directly from human donors who have natural immunity to disease.
** TIVO INC, Tuesday close $10.36, +4.05 pct premarket
The digital video recorder maker reported better-than-expected quarterly revenue and profit, helped by higher subscriptions.
** REYNOLDS AMERICAN INC, Tuesday close $75.43, flat premarket
** LORILLARD INC, Tuesday close $72.12, +0.86 pct premarket
Reynolds American on Tuesday won U.S. antitrust approval to buy smaller rival Lorillard in a deal that would combine the No. 2 and No. 3 U.S. cigarette companies.
** TOLL BROTHERS INC, Tuesday close $36.99, -0.51 pct premarket
The largest U.S. luxury homebuilder, reported a better-than-expected quarterly profit and raised the low end of its average selling price forecast for the full year as demand strengthens.
** ALIBABA GROUP HOLDING LTD, Tuesday close $92.52, -0.18 pct premarket
China's banking regulator has given a green light to MYbank, the online bank affiliated with Alibaba, to start operating.
** CITIGROUP INC, Tuesday close $54.24, +0.33 pct premarket
European banks Deutsche Bank, Barclays and UBS have seen their market share in foreign exchange trading slump in the past year, as U.S. banks led by Citigroup grabbed business, according to widely watched industry rankings.
** GENERAL ELECTRIC CO, Tuesday close $27.52, +0.18 pct premarket
GE is in advanced talks to sell assets of its vehicle fleet management business, GE Capital Fleet Services, to Element Financial Corp, Bloomberg reported, citing people familiar with the matter.
** AMAZON.COM INC, Tuesday close $425.47, +0.39 pct premarket
Amazon's decision to change its tax-efficient European business structure could raise its tax bill by as much as $100 million a year but authorities will have to fight for additional money and any payments will be hidden from public view. (Reporting by Shubhankar Chakravorty in Bengaluru; Editing by Savio D'Souza)